Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study.

Kwee TC, Vermoolen MA, Akkerman EA, Kersten MJ, Fijnheer R, Ludwig I, Beek FJ, van Leeuwen MS, Bierings MB, Bruin MC, Zsíros J, Quarles van Ufford HM, de Klerk JM, Adam J, Stoker J, Uiterwaal CS, Nievelstein RA.

J Magn Reson Imaging. 2014 Jul;40(1):26-36. doi: 10.1002/jmri.24356. Epub 2013 Oct 31.

PMID:
24307538
2.

Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.

Kwee TC, van Ufford HM, Beek FJ, Takahara T, Uiterwaal CS, Bierings MB, Ludwig I, Fijnheer R, Nievelstein RA.

Invest Radiol. 2009 Oct;44(10):683-90. doi: 10.1097/RLI.0b013e3181afbb36.

PMID:
19724232
3.

Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.

van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, Nievelstein RA, de Klerk JM.

AJR Am J Roentgenol. 2011 Mar;196(3):662-9. doi: 10.2214/AJR.10.4743.

PMID:
21343511
4.

Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.

Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL.

AJR Am J Roentgenol. 2011 Sep;197(3):W384-91. doi: 10.2214/AJR.10.5692.

PMID:
21862763
5.

Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.

Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.

Clin Cancer Res. 2014 Jun 1;20(11):2984-93. doi: 10.1158/1078-0432.CCR-13-3355. Epub 2014 Apr 2.

6.

Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.

Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, Ahlström H.

Acta Radiol. 2011 Mar 1;52(2):173-80. doi: 10.1258/ar.2010.100246.

PMID:
21498346
7.

Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.

Albano D, Patti C, La Grutta L, Agnello F, Grassedonio E, Mulè A, Cannizzaro G, Ficola U, Lagalla R, Midiri M, Galia M.

Eur J Radiol. 2016 Feb;85(2):313-8. doi: 10.1016/j.ejrad.2015.12.006. Epub 2015 Dec 12.

PMID:
26781135
8.

Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.

Littooij AS, Kwee TC, Barber I, Granata C, Vermoolen MA, Enríquez G, Zsíros J, Soh SY, de Keizer B, Beek FJ, Hobbelink MG, Bierings MB, Stoker J, Nievelstein RA.

Eur Radiol. 2014 May;24(5):1153-65. doi: 10.1007/s00330-014-3114-0. Epub 2014 Feb 23.

PMID:
24563179
9.

Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.

Stéphane V, Samuel B, Vincent D, Joelle G, Remy P, Francois GG, Jean-Pierre T.

Eur J Radiol. 2013 Nov;82(11):2011-7. doi: 10.1016/j.ejrad.2013.05.042. Epub 2013 Aug 9.

PMID:
23932096
10.

Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.

Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.

Lancet Oncol. 2014 Mar;15(3):275-85. doi: 10.1016/S1470-2045(14)70021-X. Epub 2014 Feb 19.

PMID:
24559803
11.

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V.

Eur Radiol. 2014 Apr;24(4):889-901. doi: 10.1007/s00330-013-3083-8. Epub 2013 Dec 11.

PMID:
24322510
12.

Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.

Balbo-Mussetto A, Cirillo S, Bruna R, Gueli A, Saviolo C, Petracchini M, Fornari A, Lario CV, Gottardi D, De Crescenzo A, Tarella C.

Clin Radiol. 2016 Mar;71(3):271-9. doi: 10.1016/j.crad.2015.11.018. Epub 2015 Dec 31.

PMID:
26749081
13.

Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study.

Littooij AS, Kwee TC, de Keizer B, Bruin MC, Coma A, Beek FJ, Fijnheer R, Nievelstein RA.

J Magn Reson Imaging. 2015 Dec;42(6):1646-55. doi: 10.1002/jmri.24938. Epub 2015 May 8.

PMID:
25952024
14.

Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma.

Littooij AS, Kwee TC, Barber I, Granata C, de Keizer B, Beek FJ, Hobbelink MG, Fijnheer R, Stoker J, Nievelstein RA.

Acta Radiol. 2016 Feb;57(2):142-51. doi: 10.1177/0284185115571657. Epub 2015 Feb 13.

PMID:
25681490
15.

Whole-body diffusion-weighted MRI for staging lymphoma at 3.0T: comparative study with MR imaging at 1.5T.

Azzedine B, Kahina MB, Dimitri P, Christophe P, Alain D, Claude M.

Clin Imaging. 2015 Jan-Feb;39(1):104-9. doi: 10.1016/j.clinimag.2014.06.017. Epub 2014 Jul 12.

PMID:
25108666
16.

Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studies.

Regacini R, Puchnick A, Shigueoka DC, Iared W, Lederman HM.

Sao Paulo Med J. 2015 Mar-Apr;133(2):141-50. doi: 10.1590/1516-3180.2014.8312810. Epub 2015 Mar 17. Review.

17.

Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.

Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S.

Eur J Radiol. 2012 Jan;81(1):178-82. doi: 10.1016/j.ejrad.2010.09.001. Epub 2010 Oct 6.

PMID:
20932700
18.

MRI for staging lymphoma: whole-body or less?

Kwee TC, Akkerman EM, Fijnheer R, Kersten MJ, Zsíros J, Ludwig I, Bierings MB, Vermoolen MA, van Leeuwen MS, Stoker J, Nievelstein RA.

J Magn Reson Imaging. 2011 May;33(5):1144-50. doi: 10.1002/jmri.22549.

PMID:
21509873
19.

Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.

Noij DP, Boerhout EJ, Pieters-van den Bos IC, Comans EF, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf P, Castelijns JA.

Eur J Radiol. 2014 Jul;83(7):1144-51. doi: 10.1016/j.ejrad.2014.03.019. Epub 2014 Mar 30.

20.

Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.

Tsuji K, Kishi S, Tsuchida T, Yamauchi T, Ikegaya S, Urasaki Y, Fujiwara Y, Ueda T, Okazawa H, Kimura H.

J Magn Reson Imaging. 2015 Jun;41(6):1601-7. doi: 10.1002/jmri.24714. Epub 2014 Aug 11.

PMID:
25111444

Supplemental Content

Support Center